Meet our group leader: Jarno Drost
Jarno Drost received his PhD in the group of Reuven Agami (Netherlands Cancer Institute) studying malignant transformation using RNA interference screens. He subsequently joined the lab of Hans Clevers (Hubrecht Institute) where he used organoid technology in combination with CRISPR/Cas9 gene editing to study multistep tumorigenesis. Since 2016, he is group leader at the Princess Máxima Center for Pediatric Oncology. In 2019, he became an Oncode Investigator. He received several awards, including the Bas Mulder Young Investigator Award from the Dutch Cancer Society, the ERC Starting and NWO-Vidi grants, and the AACR St. Baldrick’s career development award for emerging leaders in the field of pediatric oncology.